Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Cierra Murry is an expert in banking, credit cards, investing, loans, mortgages, and real estate. She is a ...

Can paying attention establish a new field? Learn about Thomas Hunt Morgan, the first person to definitively link trait inheritance to a specific chromosome and his white-eyed flies. Table 1 provides ...

For the 23rd year, Forbes’ Global 2000 ranks the largest public companies in the world using four metrics—sales, profits, assets and market value—and despite the geopolitical uncertainty and ...